Stay updated on Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide NIH notice about terminology changes during the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov page.
    Difference
    1%
    Check dated 2026-10-25T13:24:58.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2 while the study page remained inaccessible.
    Difference
    0.2%
    Check dated 2026-10-18T13:39:27.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:45:00.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error message with a 403 header and a Home link, replacing the expected study record content.
    Difference
    0.5%
    Check dated 2026-09-27T17:56:14.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an access-denied notice. The deletions remove the previously visible study documents and details, indicating restricted access to the record.
    Difference
    21%
    Check dated 2026-09-20T11:27:06.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6, indicating a newer revision of the study record page. It appears to be a metadata update rather than a change to study content or outcomes.
    Difference
    0.0%
    Check dated 2026-08-29T23:47:08.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.